Total raised
—
Last: Seed 2019-01
Stage
Seed
Founded
2014
Headcount
6
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
TaGeza Biopharmaceuticals is a biotechnology start-up dedicated to the study of cancer stem cells in the deadliest forms of cancer. The company seeks to identify central markers of highly aggressive cancer stem cells and develop drugs to target them, with the goal of eradicating different forms of treatment-resistant cancers. TaGeza is a spin-off company of Tel Hashomer Medical Research, Infrastructure and Services Ltd, the technology transfer arm of Sheba Medical Center.
Funding history · 1 round · — total
2019-01
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the current operational status of TaGeza Biopharmaceuticals?
- TaGeza Biopharmaceuticals is currently inactive, having ceased operations in September 2023.
- When was TaGeza Biopharmaceuticals founded?
- TaGeza Biopharmaceuticals was founded in February 2014.
- What is the primary focus of TaGeza Biopharmaceuticals?
- TaGeza Biopharmaceuticals focuses on identifying central markers of highly aggressive cancer stem cells and developing drugs to target them, aiming to eradicate treatment-resistant cancers.
- From which institution did TaGeza Biopharmaceuticals spin off?
- TaGeza Biopharmaceuticals is a spin-off company of Tel Hashomer Medical Research, Infrastructure and Services Ltd, which is the technology transfer arm of Sheba Medical Center.
- What was the last funding round for TaGeza Biopharmaceuticals?
- TaGeza Biopharmaceuticals completed a Seed funding round in January 2019, with aMoon Fund participating.
- How many employees did TaGeza Biopharmaceuticals have?
- TaGeza Biopharmaceuticals had between 1 and 10 employees, with an exact count of 6.
- Who are the founders of TaGeza Biopharmaceuticals?
- The founders of TaGeza Biopharmaceuticals are Nadav Peles and Orit Harari-Steinberg.
- What is the product stage of TaGeza Biopharmaceuticals?
- The product stage of TaGeza Biopharmaceuticals is R&D.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareLaboratoriesPatients
Business model
B2B
Tags
drug-discoveryantibodiescancerbiopharmaceuticallaboratoriespharma-companies